Less surgery may be enough for rare pancreatic tumor, study suggests
NCT ID NCT07592663
First seen May 30, 2026
Summary
This study looked at 708 patients with a rare, low-grade pancreatic tumor called solid pseudopapillary neoplasm. Researchers compared a less invasive surgery that saves healthy pancreas tissue to a more extensive surgery that removes more of the organ. They also examined whether removing nearby lymph nodes is necessary. The goal was to see if the less invasive approach is safe and effective over the long term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID PSEUDOPAPILLARY NEOPLASM OF THE PANCREAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Parenchyma-sparing resection (a less invasive surgery that removes the tumor while saving as much healthy pancreas as possible)
What this could lead to
If successful, this could show that less invasive surgery is safe for this rare tumor and that removing lymph nodes may not be necessary, helping patients recover faster with fewer long-term side effects.
What could go wrong
This is a completed observational study, not a randomized trial, so results may not apply to all patients. The tumor is low-grade, so the benefits of less surgery may not be as clear for more aggressive cancers.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.